Risk factors for acquisition of gentamicin-resistant enterococcal infection: a case-controlled study

M Viagappan1, R E Holliman

  • 1Department of Medical Microbiology, St George's Hospital & Medical School, London, UK.

Insights

High-level gentamicin-resistant enterococci (HLG શ્રે) infections pose treatment challenges. Prior prolonged antibiotic use, multiple antibiotic exposure, and urinary catheterization are key risk factors for HLG શ્રે acquisition.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Hospital Epidemiology

Background:

  • High-level gentamicin-resistant enterococci (HLG શ્રે) complicate patient treatment due to loss of synergistic antibiotic effects.
  • Understanding risk factors for HLG શ્રે acquisition is crucial for effective infection control.

Purpose of the Study:

  • To identify key risk factors associated with the acquisition of high-level gentamicin-resistant enterococci infections.
  • To inform targeted infection control strategies for at-risk patient populations.

Main Methods:

  • A case-controlled study was conducted involving patients infected with resistant and sensitive enterococcal strains.
  • Data collected from 17 patients with HLG શ્રે infections and 26 patients with sensitive strains at a London hospital.

Main Results:

  • Prior prolonged antibiotic treatment emerged as a significant risk factor for HLG શ્રે.
  • The use of five or more antibiotics was strongly associated with HLG શ્રે acquisition.
  • Presence of a urinary catheter was identified as a key risk factor for HLG શ્રે infection.

Conclusions:

  • Infection control measures should prioritize patients exhibiting identified risk factors for HLG શ્રે.
  • Stricter antibiotic stewardship within hospitals may reduce the incidence and spread of HLG શ્રે.

Related Concept Videos

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...